Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53.6M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
2.78M
-
Shares change
-
+2.77M
-
Total reported value, excl. options
-
$4.64M
-
Value change
-
+$4.63M
-
Put/Call ratio
-
1.26
-
Number of buys
-
11
-
Price
-
$1.67
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q3 2022
14 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share as of Q3 2022.
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.78M shares
of 53.6M outstanding shares and own 5.19% of the company stock.
Largest 10 shareholders include Abingworth LLP (1.2M shares), Nantahala Capital Management, LLC (604K shares), AIGH Capital Management LLC (424K shares), Granite Point Capital Management, L.P. (176K shares), VANGUARD GROUP INC (121K shares), Worth Venture Partners, LLC (106K shares), J. Goldman & Co LP (45K shares), RENAISSANCE TECHNOLOGIES LLC (45K shares), GEODE CAPITAL MANAGEMENT, LLC (32.6K shares), and STATE STREET CORP (15.4K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.